• SUBSTIPHARM BIOLOGICS SA

    GE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-660.2.196.022-9
    Sector: Research and development

    Age of the company

    3 years

    Turnover in CHF

    PremiumPremium

    Kapital in EUR

    21,0 Mio.

    Employees

    PremiumPremium

    Active brands

    0

    Reports for SUBSTIPHARM BIOLOGICS SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About SUBSTIPHARM BIOLOGICS SA

    • SUBSTIPHARM BIOLOGICS SA from Grand-Lancy operates in the sector «Research and development» and is active.
    • SUBSTIPHARM BIOLOGICS SA has 6 persons entered in its management.
    • On the 12.08.2024 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The Enterprise Identification Number of the company SUBSTIPHARM BIOLOGICS SA is the following: CHE-138.874.539.
    • There are 65 other active companies that have registered an identical address. These include: A&M PAYSAGE Sàrl, ABM Construction Sàrl, AVT Rénovation Sàrl.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    La société a pour but l'acquisition, le développement et l'exploitation de médicaments, vaccins et autres produits pharmaceutiques. La société peut, en outre, effectuer, pour son compte, toutes opérations financières, commerciales ou mobilières se rattachant directement ou indirectement à son but social et s'intéresser, sous toutes formes, à toutes entreprises ayant un but similaire, notamment par la prise de participations dans de telles entreprises. La société pourra constituer des succursales et des filiales en Suisse et à l'étranger. Dans le cadre de son but, la société peut également acquérir et détenir des biens immobiliers suisses ou des actions de sociétés ayant un but similaire et détenant des biens immobiliers suisses pour autant qu'ils aient une affectation exclusivement commerciale ou industrielle.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    WHAT'S UP SA
    Carouge (GE) 24.04.2023

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Es sind keine früheren oder übersetzten Firmannamen vorhanden.

    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: SUBSTIPHARM BIOLOGICS SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 240812/2024 - 12.08.2024
    Categories: Miscellaneous changes

    Publication number: HR02-1006104995, Commercial Registry Office Geneva, (660)

    SUBSTIPHARM BIOLOGICS SA, à Lancy, CHE-138.874.539 (FOSC du 22.05.2023, p. 0/1005751230).

    Communication aux actionnaires:
    par courrier simple ou par courriel. Nouveaux statuts du 17.07.2024.

    SOGC 230522/2023 - 22.05.2023
    Categories: Change in management

    Publication number: HR02-1005751230, Commercial Registry Office Geneva, (660)

    SUBSTIPHARM BIOLOGICS SA, à Lancy, CHE-138.874.539 (FOSC du 24.04.2023, p. 0/1005730979). Signature collective à deux a été conférée à Profit Hervé, de France, à Lyon, FRA, directeur.

    SOGC 230424/2023 - 24.04.2023
    Categories: Change of auditors

    Publication number: HR02-1005730979, Commercial Registry Office Geneva, (660)

    SUBSTIPHARM BIOLOGICS SA, à Lancy, CHE-138.874.539 (FOSC du 03.03.2023, p. 0/1005692970). Radiation de la mention relative à la renonciation à un contrôle restreint.

    Organe de révision:
    WHAT'S UP SA (CHE-116.299.093), à Carouge (GE).

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm